Anika Therapeutics (ANIK) Receivables (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Receivables of $29.7 million for Q2 2026, up 19.83% year-over-year from $24.8 million in Q2 2025, and up 10.44% quarter-over-quarter from $26.9 million in Q1 2026.
Anika Therapeutics (ANIK) Receivables (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Receivables for 17 consecutive years, with $29.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Receivables rose 19.83% year-over-year to $29.7 million; the TTM figure through Jun 2026 stood at $29.7 million (up 19.83% YoY), while the FY2025 annual figure was $24.8 million, up 2.03% from the prior year.
- Receivables climbed to $29.7 million in Q2 2026 per ANIK's latest filing, from $26.9 million in the prior quarter.
- Across five years, Receivables topped out at $38.4 million in Q2 2023 and bottomed at $22.7 million in Q1 2025.
- Historically, Receivables has averaged $30.0 million across 5 years, with a median of $29.7 million in 2026.
- Annual changes were most pronounced in 2025 — Receivables plunged 32.7% — and 2026, when it increased 19.83%.
- Anika Therapeutics' Receivables stood at $36.2 million in 2022, then retreated by 25.41% to $27.0 million in 2023, then dropped by 10.0% to $24.3 million in 2024, then rose by 2.03% to $24.8 million in 2025, then grew by 19.52% to $29.7 million in 2026.
- Business Quant data shows ANIK's Receivables at $29.7 million in Q2 2026, $26.9 million in Q1 2026, and $24.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.08 Bn |
| 10 | Anika Therapeutics | 284.33 Mn | 245.92 Mn | 21.24 Mn | 29.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.66 Mn |
| Mar 31, 2026 | 26.86 Mn |
| Dec 31, 2025 | 24.82 Mn |
| Sep 30, 2025 | 23.06 Mn |
| Jun 30, 2025 | 24.75 Mn |
| Mar 31, 2025 | 22.70 Mn |
| Dec 31, 2024 | 24.32 Mn |
| Sep 30, 2024 | 30.93 Mn |
| Jun 30, 2024 | 35.40 Mn |
| Mar 31, 2024 | 33.74 Mn |
| Dec 31, 2023 | 27.03 Mn |
| Sep 30, 2023 | 36.26 Mn |
| Jun 30, 2023 | 38.36 Mn |
| Mar 31, 2023 | 35.42 Mn |
| Dec 31, 2022 | 36.24 Mn |
| Dec 31, 2021 | 31.29 Mn |
| Sep 30, 2021 | 32.35 Mn |
| Jun 30, 2021 | 29.43 Mn |
| Mar 31, 2021 | 26.51 Mn |
| Dec 31, 2020 | 24.10 Mn |